Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 543298 | NSE Symbol : VINEETLAB | ISIN : INE505Y01010 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
04-Feb-2025	12-Feb-2025	Quarterly Results	Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the unaudited standalone financial results of the company for the third quarter ended on December 31 2024 along with limited review report. The Board of Directors of the company in its meeting held today Le., on February 12, 2025 has considered and approved Un-audited Standalone Financial Results along with limited review report of the Company for the third quarter and nine months ended on December 31, 2024. This is to inform you that the Board of Directors in their meeting held on Wednesday, February 12, 2025 has considered and approved un-audited standalone financial results along with limited review report of the company for the third quarter and nine months ended on December 31, 2024. (As Per BSE Announcement Dated on 12/02/2025)
05-Nov-2024	13-Nov-2024	Quarterly Results	Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve the unaudited standalone financial results of the Company for the second quarter and half-year ended on 30th September 2024 along with the Limited Review Report. This is to inform that the Board of Directors in its meeting held on Wednesday, i.e November 13,2024 has: Considered and approved un-audited standalone financial results of the company for the second quarter and half-year ended on 30th September, 2024. Noted the resignation of Mr. Bhaskara Reddy Karna from the office of Independent Director w.e.f the conclusion of the meeting The Board of Directors of the company in its meeting held today i.e., on November 13, 2024 has : Considered and approved Un-audited Standalone Financial Results of the Company for the second quarter and half year ended on 30th September, 2024. Noted the resignation of Mr. Bhaskara Reddy Karna (DIN: 08961904) from the office of Independent Director w.e.f the conclusion of the Board Meeting (As per BSE Announcement Dated on 13/11/2024)
31-Jul-2024	13-Aug-2024	Quarterly Results	Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve The unaudited standalone financial results of the Company for the first quarter ended on 30th June 2024 along with the Limited Review Report. The Board of Directors of the company in its meeting held today i.e., on August 13, 2024 has considered and approved the following: Unaudited Standalone Financial Results of the company for the First Quarter ended on June 30, 2024 along with the Limited Review Report submitted by the Statutory Auditors. (As per BSE Announcement dated on 13/08/2024)
21-May-2024	29-May-2024	Accounts	Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the audited standalone financial results of the Company for the 4th quarter and the financial year ended on March 31 2024 The Board of Directors of the company in its meeting held today i.e., on May 29, 2024 has : Considered and approved Audited Standalone Financial Results of the Company for the 4th .... Read More.. The Board of Directors of the company in its meeting held today i.e. , on May 29, 2024 has : Taken note of resignation of Mr. Satish Pandurang Samant (DIN : 10294920) from the office of Executive Director w.e.f May 29, 2024. Approved the resignation of Mr. Satish Pandurang Samant (DIN : 10294920) from the office of Chief Executive Officer w.e.f May 29, 2024. Read less.. The Board of Directors of the company in its meeting held today i.e. , on May 29, 2024 has : Approved the resignation of Mr. Satish Pandurang Samant (DIN : 10294920) from the office of Chief Executive Officer w.e.f May 29, 2024. Read less.. (As Per BSE Announcement Dated on 29.05.2024)
02-Feb-2024	12-Feb-2024	Quarterly Results	Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve unaudited financial results of the Company for the 3rd quarter and the nine months period ended on December 31 2023 along with the Limited Review Report Unaudited Financial Results and Limited Review Report for the Third Quarter and the Nine months ended 31st December 2023. (As Per BSE Announcement dated on 12.02.2024)
02-Nov-2023	10-Nov-2023	Quarterly Results	Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday November 10 2023. The purpose of the Board Meeting is - among other matters- to consider and approve the unaudited financial results of the Company for the 2nd quarter and the half year ended on September 30 2023 along with the Limited Review Report. VINEET LABORATORIES LIMITED has informed BSE about Board Meeting to be held on 10 Nov 2023 to consider financial statements for the period ended September 2023. Financial results. The Board of Directors of the company in its meeting held today i.e., on November 10, 2023 has considered and approved the following: Unaudited Financial Results of the company for the Second Quarter and Half year ended on September 30, 2023 along with the Limited Review Report submitted by the Statutory Auditors. Appointment of Mr. Rameshkumar Bandari (Membership No: A24519) as the Company Secretary and Compliance Officer of the Company with effect from November 10, 2023 The Board of Directors have approved the Unaudited Financial results along with Limited Review Report for the Second quarter and Half year ended on September 30, 2023. The Board of Directors have approved the appointment of Mr. Rameshkumar Bandari (M.No A24519) as the Company Secretary and Compliance Officer of the Company with effect from November 10, 2023. (As Per BSE Announcement Dated on 10.11.2023) In continuation to our earlier announcement dated November 10, 2023 relating to the outcome of meeting of Board of Directors held on November 10, 2023 , This is to inform you that in the said announcement we have inadvertently enclosed the Cash Flow Statement, which was not in line in with the Profit & Loss Account and the Statement of Assets and Liabilities. Hence, in compliance with Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are herewith resubmitting complete set of Un-audited financial results along with Limited Review Report for the Second quarter and the Half year ended on September 30, 2023. (As Per BSE Announcement Dated on 11.11.2023)
16-Oct-2023	16-Oct-2023	Change in Directors	The Board of Directors of the company in its meeting held today i.e., on October 16, 2023 has approved the appointment of Mr. Satish Pandurang Samant (DIN: 10294920) as an Additional Executive Director and Chief Executive Officer (CEO) of the Company effective October 16, 2023.
04-Aug-2023	12-Aug-2023	Quarterly Results	Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve The purpose of the Board Meeting is - among other matters- To consider & approve the unaudited financial results along with limited review report of the company for the first quarter ended 30th June 2023. The Board of Directors of the company in its meeting held today i.e., on August 12, 2023 has approved the following: 1. Un-audited Financial Results along with Limited Review Report of the Company for the First Quarter ended on June 30, 2023. 2. Appointment of one of the Promoters, Mr. Alluri Ranga Raju (DIN: 10044882) as Additional Non-Executive Director of the company. 3. Resignation of Mr. Kandula Murali Mohan (DIN: 03313407) as Whole Time Director of the Company w.e.f the business closing hours of August 12, 2023. 4. Re-appointment and fixing of remuneration of Mr. Gaddam Venkata Ramana (DIN: 00031873) as the Managing Director of the company for a term of three years. 5. Re-appointment and fixing of remuneration of Mr. Satyanarayana Raju Bhupathiraju (DIN: 02697880) as Whole - Time Director of the company for a term of three years (As per BSE Announcement Dated on 12/08/2023)
18-May-2023	29-May-2023	Accounts	Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Monday May 29 2023. The purpose of the Board Meeting is - among other matters- to consider and approve the audited financial results of the Company for the 4th quarter and financial year ended on March 31 2023. Submission of complete set of Audited financial results for the fourth quarter and year ended 31st March, 2023 (As Per BSE Announcement dated on 29.05.2023)
07-Feb-2023	14-Feb-2023	Quarterly Results	Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday February 14 2023. The purpose of the Board Meeting is - among other matters- to consider and approve the unaudited financial results of the Company for the 3rd quarter ended on December 31 2022 along with the Limited Review Report. In accordance with the SEBI (Prohibition of Insider Trading) Regulations 2015 read with the Code of Conduct to Regulate Monitor and Report Trading by Insiders of the Company the Trading Window for dealing in the equity shares of the Company was closed from January 1 2023 till 48 hours after the announcement of financial results to all the designated persons their immediate relatives and all connected persons covered under the said Code. Therefore the Trading Window remains closed till Thursday February 16 2023. The Board of Directors of the company in its meeting held today i.e., on February 14, 2023 has considered and approved the Unaudited Financial Results of the company for the Third Quarter and Nine months ended on December 31, 2022 along with the Limited Review Report. (As Per BSE Announcement Dated on 14.02.2023)
07-Nov-2022	14-Nov-2022	Quarterly Results	Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve the unaudited financial results of the Company for the 2nd quarter ended on September 30 2022 along with the Limited Review Report. The Board of Directors of the company in its meeting held today i.e., on November 14, 2022 has considered and approved the Unaudited Financial Results of the company for the Second Quarter and Half Year ended on September 30, 2022 along with the Limited Review Report submitted by the Statutory Auditors. (As Per BSE Announcement Dated on 14.11.2022) Newspaper Publication of the Un-audited Financial Results for the 2nd quarter ended on 30th September, 2022 (As Per BSE Announcement Dated on 16/11/2022)
30-Aug-2022	30-Aug-2022	Quarterly Results	The Board of Directors of the company in its meeting held today i.e., on August 30, 2022 has approved the following: 1. Directors' Report along with annexures thereto including Corporate Governance Report for the year ended 31st March 2022. 2. Notice of the 6th Annual General Meeting to be held in Physical mode on Wednesday, September 28, 2022, at 11:00 a.m. IST.
21-Jul-2022	29-Jul-2022	Quarterly Results	Quarterly Results With reference to the above-mentioned subject, we hereby submit the revised Audited Financial Results of the company for the Fourth Quarter and the Financial Year ended on 31st March, 2022. More specifically, rectifying the figures (Total Comprehensive Income and EPS) for the quarter ended 31st March, 2022. The error was unintentional and due to oversight. Inconvenience regretted. (As Per BSE Announcement Dated on 23.07.2022) Considered and adopted unaudited Financials results for Quarter ended June 30,2022 along with Limited review Report (As per BSE Announcement Dated on 29/07/2022)
20-May-2022	28-May-2022	Accounts	Audited Results Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, May 28, 2022 at 4:00pm. The purpose of the Board Meeting is - among other matters- 1. The Annual Audited Financial Results for the Fourth Quarter and Financial Year ended 31st March 2022; 2. The Annual Audited Financial Statements for the financial year 2021-2022; 3. Other Corporate Matters. The Board of Directors in the meeting held on 28 May, 2022 has recommended Final Dividend at Re.1/- per equity share of Face Value of Rs.10 each for the financial year ended March 31, 2022. The Board of Directors of the company in its meeting held today i.e., on May 28, 2022 has considered and approved the following: 1. The Annual Audited Financial Results of the company for the Fourth Quarter and the Financial Year ended on 31st March, 2022; 2. The Annual Audited Financial Statements for the financial year 2021-2022; 3. Independent Auditor's Report on Quarterly Standalone Financial Results and Year to Date. 4. Recommended Final Dividend at Re.1/- per equity share of Face Value of Rs.10 each for the financial year ended March 31, 2022. The Board Meeting commenced at 04.00 PM and concluded at 08.00 PM (As Per BSE Announcement Dated on 28/05/2022)
04-Feb-2022	12-Feb-2022	Quarterly Results	Quarterly Results The Board of Directors of the company in its meeting held on February 12, 2022 has considered and approved the Un-audited Financial Results of the company for the Quarter and Nine months ended on 31st December, 2021; Limited Review Report issued by the Statutory Auditor (As Per BSE Announcement Dated on 12.02.2022)

1 2

LOGIN HERE

Vineet Laboratories Ltd

Board Meeting